Suivre
Mathieu Charvériat
Mathieu Charvériat
Theranexus
Adresse e-mail validée de theranexus.com - Page d'accueil
Titre
Citée par
Citée par
Année
Impact of astroglial connexins on modafinil pharmacological properties
A Duchêne, M Perier, Y Zhao, X Liu, J Thomasson, F Chauveau, ...
Sleep 39 (6), 1283-1292, 2016
592016
Antidepressants impact connexin 43 channel functions in astrocytes
T Jeanson, A Pondaven, P Ezan, F Mouthon, M Charvériat, C Giaume
Frontiers in cellular neuroscience 9, 495, 2016
592016
Connexin-dependent neuroglial networking as a new therapeutic target
M Charvériat, CC Naus, L Leybaert, JC Sáez, C Giaume
Frontiers in Cellular Neuroscience 11, 174, 2017
542017
Human connexin channel specificity of classical and new gap junction inhibitors
C Picoli, V Nouvel, F Aubry, M Reboul, A Duchêne, T Jeanson, ...
Journal of biomolecular screening 17 (10), 1339-1347, 2012
392012
Potentiation of amitriptyline anti-hyperalgesic-like action by astroglial connexin 43 inhibition in neuropathic rats
T Jeanson, A Duchêne, D Richard, S Bourgoin, C Picoli, P Ezan, ...
Scientific Reports 6 (1), 38766, 2016
322016
Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
F Mouthon, M Charveriat, JP Deslys, F Iris
US Patent App. 13/063,409, 2011
29*2011
Dissociated features of social cognition altered in mouse models of schizophrenia: Focus on social dominance and acoustic communication
A Faure, A Nosjean, E Pittaras, A Duchêne, A Andrieux, S Gory-Fauré, ...
Neuropharmacology 159, 107334, 2019
192019
High-content screening identifies new inhibitors of connexin 43 gap junctions
C Picoli, E Soleilhac, A Journet, C Barette, M Comte, C Giaume, ...
ASSAY and Drug Development Technologies 17 (5), 240-248, 2019
192019
Cortico-amygdala-striatal activation by modafinil/flecainide combination
D Vodovar, A Duchêne, C Wimberley, C Leroy, G Pottier, Y Dauvilliers, ...
International Journal of Neuropsychopharmacology 21 (7), 687-696, 2018
192018
New inhibitors of prion replication that target the amyloid precursor
M Charveriat, M Reboul, Q Wang, C Picoli, N Lenuzza, A Montagnac, ...
Journal of general virology 90 (5), 1294-1301, 2009
192009
Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40‐hour total sleep deprivation in healthy subjects: Glial connexins as a …
F Sauvet, M Erblang, D Gomez‐Merino, A Rabat, M Guillard, ...
British journal of clinical pharmacology 85 (11), 2623-2633, 2019
182019
Functional ultrasound imaging to study brain dynamics: application of pharmaco-fUS to atomoxetine
B Vidal, M Droguerre, L Venet, L Zimmer, M Valdebenito, F Mouthon, ...
Neuropharmacology 179, 108273, 2020
172020
Pharmaco-fUS for characterizing drugs for Alzheimer’s disease–the case of THN201, a drug combination of donepezil plus Mefloquine
B Vidal, M Droguerre, M Valdebenito, L Zimmer, M Hamon, F Mouthon, ...
Frontiers in Neuroscience 14, 835, 2020
152020
Connexins as therapeutic targets in neurological and neuropsychiatric disorders
M Charvériat, F Mouthon, W Rein, A Verkhratsky
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (5), 166098, 2021
142021
Efficacy of THN201, a combination of donepezil and mefloquine, to reverse neurocognitive deficits in Alzheimer’s disease
M Droguerre, A Duchêne, B Portal, BP Guiard, J Meunier, V Villard, ...
Frontiers in neuroscience 14, 544939, 2020
142020
A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain
M Droguerre, T Tsurugizawa, A Duchêne, B Portal, BP Guiard, N Déglon, ...
Scientific reports 9 (1), 18292, 2019
142019
Innovative approaches in CNS drug discovery
M Charveriat, V Lafon, F Mouthon, L Zimmer
Therapies 76 (2), 101-109, 2021
102021
Modeling and targeting neuroglial interactions with human pluripotent stem cell models
J Bigarreau, N Rouach, AL Perrier, F Mouthon, M Charvériat
International Journal of Molecular Sciences 23 (3), 1684, 2022
82022
Evaluating and modulating TFEB in the control of autophagy: toward new treatments in CNS disorders
A da Costa, T Metais, F Mouthon, D Kerkovich, M Charvériat
Fundamental & clinical pharmacology 35 (3), 539-551, 2021
82021
Clinical pharmacology: Current innovations and future challenges
JL Cracowski, JS Hulot, S Laporte, M Charvériat, M Roustit, D Deplanque, ...
Fundamental & Clinical Pharmacology 36 (3), 456-467, 2022
62022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20